Evidence map›Paper›PMID 31134641›Full record

ArticleAnnals of the New York Academy of Sciences2019

Replacing iron-folic acid with multiple micronutrient supplements among pregnant women in Bangladesh and Burkina Faso: costs, impacts, and cost-effectiveness.

Reina Engle-Stone, Sika M Kumordzie, Laura Meinzen-Dick, Stephen A Vosti

2 registry-linked trialsAbstract read
In one paragraph

Article in Annals of the New York Academy of Sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 26 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05312242 nacompletednot on this mapstarted 2022, after this paper: background citation

Introduction of Multiple Micronutrient Supplementation to Antenatal Care in Bamako, Mali

TypeinterventionalSponsorJohns Hopkins Bloomberg School of Public HealthRan2022 to 2023Enrolled486ConditionsAdherence, MedicationArmsUnited Nations International Multiple Micronutrient Antenatal Preparation (UNIMMAP) MMS, Iron Folic Acid Supplement
NCT07540130 phase1 / phase2active not recruitingnot on this mapstarted 2025, after this paper: background citation

Effectiveness of Multiple Micronutrient Supplementation Compared With Iron-Folic Acid Supplementation Among Pregnant Women in Bangladesh: an Experimental Protocol With 12-month Follow-up

TypeinterventionalSponsorNational Institute of Neurosciences and Hospital, DhakaRan2025 to 2026Enrolled667ConditionsPregnant Women, Pregnant Women and Their OffspringArmsMultiple micronutrient supplementation, Iron Folic Acid alone - Placebo
3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Reina Engle-StoneDepartment of Nutrition, University of California - Davis, Davis, California.
Sika M KumordzieDepartment of Nutrition, University of California - Davis, Davis, California.
Laura Meinzen-DickDepartment of Agricultural and Resource Economics, University of California - Davis, Davis, California.
Stephen A VostiProgram in International and Community Nutrition, University of California - Davis, Davis, California.

Funding

Bill & Melinda Gates FoundationSight and Life
6 · The paper itself

Abstract

Consumption of multiple micronutrient supplements (MMS) during pregnancy offers additional benefits compared with iron-folic acid (IFA) supplementation, but the tablets are more expensive. We estimated the effects, costs, and cost-effectiveness of hypothetically replacing IFA supplements with MMS for 1 year in Bangladesh and Burkina Faso. Using baseline demographic characteristics from LiST and effect sizes from a meta-analysis, we estimated the marginal effects of replacing IFA with MMS on mortality, adverse birth outcomes, and disability-adjusted life years (DALYs) averted. We calculated the marginal tablet costs of completely replacing MMS with IFA (assuming 180 tablets per covered pregnancy). Replacing IFA with MMS could avert over 15,000 deaths and 30,000 cases of preterm birth annually in Bangladesh and over 5000 deaths and 5000 cases of preterm birth in Burkina Faso, assuming 100% coverage and adherence. We estimated the cost per death averted to be US$175-185 in Bangladesh and $112-125 in Burkina Faso. Cost per DALY averted ranged from $3 to $15, depending on the country and consideration of subgroup effects. Our estimates suggest that this policy change would cost-effectively save lives and reduce life-long disabilities. Improvements in program delivery and supplement adherence would be expected to improve the cost-effectiveness of replacing IFA with MMS.

Indexed as

Cost-Benefit AnalysisBangladeshBurkina FasoFemaleFolic AcidHumansIronMicronutrientsPregnancyPregnancy OutcomeFolic AcidIronMicronutrientscost-effectivenessiron-folic acidmultiple micronutrient supplementpregnancysupplementation

Identifiers

PMID31134641
PMCPMC6771790

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.